Allon Therapeutics, Inc. Announces PSP Clinical Trial Results
12/19/2012 8:39:45 AM
More...
|
Allon Therapeutics, Inc. Release: the United States, New Zealand & Mexico Issue Patent for New Allon Platform
12/5/2012 9:29:23 AM
More...
|
Allon Therapeutics, Inc. Selected as Top 10 Partnering Prospect by CNS Experts
11/29/2012 10:02:47 AM
More...
|
Allon Therapeutics, Inc. Files Preliminary Shelf Prospectus
11/26/2012 10:43:42 AM
More...
|
Patient Treatment Completed in Pivotal Trial Evaluating Allon Therapeutics, Inc.'s Davunetide
11/13/2012 11:19:27 AM
More...
|
Allon Therapeutics, Inc. Releases Q3 Operating Results and Provides Corporate Update
11/6/2012 10:17:15 AM
More...
|
Allon Therapeutics, Inc.'s CEO Presenting at 2012 Biotechnology Industry Organization (BIO) Investor Forum and Updating Guidance
10/11/2012 11:46:04 AM
More...
|
Allon Therapeutics, Inc. Releases Q2 Operating Results and Provides Corporate Update
8/8/2012 12:17:32 PM
More...
|
Allon Therapeutics, Inc. Presents Baseline Data from PSP Clinical Trial to Alzheimer's Conference
7/16/2012 10:15:46 AM
More...
|
Allon Therapeutics, Inc. CEO Updates Bloom Burton & Co. Healthcare Investor Conference
6/22/2012 10:18:42 AM
More...
|
|